Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05722639 · ClinicalTrials.gov registry record
Evaluation of Accuracy and Consistency of the X-Trodes System
A clinical trial of Equipment and Supplies, sponsored by B-Cube.
- Completed
- Registry status
- 57
- Enrollment target
- 1
- Study location
NCT05722639: Completed study of Equipment and Supplies, sponsored by B-Cube.
NCT05722639 is a study of Equipment and Supplies that has completed, run by B-Cube. The registered enrollment target is 57 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05722639, a study of Equipment and Supplies, has completed, sponsored by B-Cube.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the accuracy and consistency of the X-Trodes acquisition system compared to a Food and Drug Administration (FDA)-cleared clinical electrophysiology device.
Primary Outcome
Electrophysiological time-series (EEG, EOG, ECG, EMG) in 2 recorded devices will be compared. For each subject, the time-series from 2 devices will be assessed by three independent raters (US board-certified neurologist/cardiologist). The raters will rank the quality of signals (1-signal is corrupt or unusable; 5-signal is clean and useable). Raters will be blind to the signal device. Time-series will be deemed interpretable if at least 2 of the raters scored it 4-5. Following the rater evalu
Conditions Studied
Interventions
- DEVICE X-Trodes acquisition system
Study Locations (1)
Illinois
- B-Cube - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2023-01-23 |
| Est. Completion | 2024-01-04 |
What the finished NCT05722639 record still lists
NCT05722639 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 1 condition, with Equipment and Supplies appearing as the primary indexed condition, and to 1 intervention - of which X-Trodes acquisition system is the first listed.
NCT05722639 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05722639 about?
NCT05722639 is a clinical study titled "Evaluation of Accuracy and Consistency of the X-Trodes System". The purpose of this study is to evaluate the accuracy and consistency of the X-Trodes acquisition system compared to a Food and Drug Administration (FDA)-cleared clinical electrophysiology device.
What is the current status of trial NCT05722639?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2023-01-23. Estimated completion is 2024-01-04.
What conditions does trial NCT05722639 study?
This clinical trial studies the following conditions: Equipment and Supplies.
What interventions are being tested in trial NCT05722639?
The interventions under investigation include: X-Trodes acquisition system (DEVICE).
Who is sponsoring clinical trial NCT05722639?
This trial is sponsored by B-Cube, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05722639 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Equipment and Supplies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI